Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-29
2010-06-15
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S278000
Reexamination Certificate
active
07737155
ABSTRACT:
The present invention provides compounds of Formula (I):and pharmaceutically acceptable salts, solvates, esters, and tautomers thereof, wherein:Q is selected from the group consisting of:andL is selected from the group consisting of:pharmaceutically compositions comprising one or more compounds of formula (I), and methods of using the compounds of formula (I).
REFERENCES:
patent: 2826580 (1958-03-01), Fischer et al.
patent: 6399653 (2002-06-01), Henke
patent: 2003/0019956 (2003-01-01), Rodriguez-Amaya
patent: 2003/0199526 (2003-10-01), Choquette et al.
patent: 2004/0122033 (2004-06-01), Nargund et al.
patent: 2004/0142377 (2004-07-01), Unett et al.
patent: 2004/0229844 (2004-11-01), Cheng et al.
patent: 2005/0251869 (2005-11-01), Cai et al.
patent: 2006/0264489 (2006-11-01), Palani et al.
patent: 2007/0065917 (2007-03-01), Chen et al.
patent: 2007/0066630 (2007-03-01), Palani et al.
patent: 2007/0167469 (2007-07-01), Bourrie et al.
patent: 2007/0173495 (2007-07-01), Palani et al.
patent: 263 891 (1989-01-01), None
patent: 265 760 (1989-03-01), None
patent: 2563223 (1985-01-01), None
patent: WO 00/69829 (2000-11-01), None
patent: WO 02/084298 (2002-10-01), None
patent: WO 2004/037159 (2004-05-01), None
patent: WO 2004/047755 (2004-06-01), None
patent: WO 2004/083388 (2004-09-01), None
patent: WO 2004/110368 (2004-12-01), None
patent: WO 2004/110375 (2004-12-01), None
patent: WO 2005/000217 (2005-01-01), None
patent: WO 2005/077950 (2005-08-01), None
patent: WO 2005/105097 (2005-11-01), None
patent: WO 2006/045564 (2006-05-01), None
patent: WO 2006/045565 (2006-05-01), None
patent: WO 2006/078834 (2006-07-01), None
patent: WO 2006/089009 (2006-08-01), None
patent: WO 2006/092430 (2006-09-01), None
patent: WO 2007/021744 (2007-02-01), None
patent: WO 2007/027661 (2007-03-01), None
patent: WO 2008/127591 (2008-10-01), None
Vippagunta et al. ,Advanced Drug Delivery Reviews, 2001, 48, 3-26.
Griesser, Chapter 8, The Importance of Solvates (pp. 211-230), in the text, Polymorphism: In the Pharmaceutical Industry, Hilfiker, 2006.
Ahluwalia et al., “Base Catalysed Condensation of Acetone with Uracil Derivatives: One Step Synthesis of Pyranopyrimidines”,Synthetic Communications, 17(12):1435-1440 (1987).
Kvita et al., “158. Reaktionen des Cumalinsaure-methylesters and Cumalinaldehyds mit ambidenten Nucleophilen”,Helv. Chim, Acta., 71:1467-1473 (1988).
Selles et al., “Expedient Synthesis of Highly Substituted Fused Heterocoumarins”;Organic Letters, 6( 2):277-279 (1997).
Tietze et al., “Multicomponent Domino Reactions for the Synthesis of Biologically Active Natural Products and Drugs”,Medicinal Research Reviews, 20:304-322 (2000).
Zooroob et al., 1,3-Dimethylpyrimidoheterozyklen als antibakterielle Substanzen,Arzneimittel-Forschung, 47:958-962 (1997).
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002482949 retrieved from CrossFire Database accession Nos. 5954253, 595391 and 5975043 Abstract.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002482950 retrieved from CrossFire Database accession No. 233231 Abstract.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002482951 retrieved from CrossFire Database accession Nos. 5935847, 5942970, 5959486 Abstract.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002482952 retrieved from CrossFire Database accession No. 191230 Abstract.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002482953 retrieved from CrossFire Database accession No. 1037486 Abstract.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002482954 retrieved from CrossFire Database accession No. 617130 Abstract.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002482955 retrieved from CrossFire Database accession No. 1018983 Abstract.
Database Beilstein, Beilstein institute for Organic Chemistry, Frankfurt-Main, DE; XP002482956 retrieved from CrossFire Database accession No. 1128908 Abstract.
Chemical Abstract No. 45:8600 for Ridi, Mario, et al., “Barbituric acid and its derivatives. VII. Some reactions with ethyl acetate”, Gazzetta Chimica Italiana 80:121-128, (1950) (which is attached to said abstract).
Chemical Abstract No. 48:3424 for Ridi, Mario, et al., “Barbituric acid and its derivatives. XI. Some reactions with esters of ketonic acids”, Gazzetta Chimica Italiana 82:23-30, (1952) (which is attached to said abstract).
Paterson, Thomas, et al, “Specific Enzyme Inhibitors in Vitamin Biosynthesis; Part I. The Synthesis of 8-Substituted Pyrido [2,3-d] Pyrimidines”, J. Chem. Soc., Perkin Trans. I, 8:1041-1050 (1972).
Rao, A. Subba, et al., “Synthesis of Heterocycles: Part ll—Pyrano[2,3-d]pyrimidines”, Indian Journal of Chemistry, 12:1028-1030 (1974).
Skof, Marko, et al. “A One-Step Transformation of (S)-1-Benzoyl-3-[(E)-Dimethylaminomethylidene]-5-Methoxycarbonyl-Pyrrolidin-2-One Into quinolizinyl-AND 2H-2- Pyranonyl-Substituted Alanine Derivatives”, Heterocycles, 51(5):1051-1058 (1999).
Toplak, Renata, et al. “The Synthesis of Methyl-2-(Benzyloxycarbonyl)amino-3-dimethylaminopropenoate. The Synthesis of Trisubstituted Pyrroles, 3-Amino-2H-pyran-2ones, Fused 2H-Pyran-2-ones and 4H Pyridin-4-ones”, J. Heterocyclic Chem., 36:225-235 (1999).
Habib, Nargues S., et al., “Synthesis of 2H-Pyrano[2,3-d]pyrimidine Derivatives”, Monatshefte fur Chemie, 115:1459-1466 (1984).
PCT International Search Report dated Dec. 28, 2006 for corresponding PCT Application No. PCT/US2006/018186.
Office Action mailed Oct. 26, 2007 in connection with U.S. Appl. No. 11/432,133 (10 Pages).
Office Action mailed Feb. 29, 2008 in connection with U.S. Appl. No. 11/432,133 (16 Pages).
Office Action mailed Oct. 3, 2008 in connection with U.S. Appl. No. 11/432,133 (15 Pages).
Office Action mailed Oct. 26, 2007 in connection with U.S. Appl. No. 11/600,216 (9 Pages).
Office Action mailed Jan. 8, 2008 in connection with U.S. Appl. No. 11/600,216 (15 Pages).
Office Action mailed Sep. 19, 2008 in connection with U.S. Appl. No. 11/600,216 (6 Pages).
Office Action mailed Oct. 3, 2008 in connection with U.S. Appl. No. 11/654,137 (6 Pages).
Aslanian Robert G.
Chen Xiao
Huang Xianhai
Huang Ying R.
Palani Anandan
Bergman Jeffrey P.
Jaisle Cecilia M
Kalyanaraman Palaiyur S.
Schering Corporation
Wilson James O
LandOfFree
Nitrogen-containing heterocyclic compounds and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrogen-containing heterocyclic compounds and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen-containing heterocyclic compounds and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4247860